BCM
LLY icon

Bayesian Capital Management’s Eli Lilly LLY Stock Holding History

Bayesian Capital Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-473
Closed -$391K – 732
2025
Q1 		$391K Buy
+473
New +$394K 0.06% 337
2024
Q4 		– Sell
-1,220
Closed -$1.08M – 858
2024
Q3 		$1.08M Buy
+1,220
New +$1.1M 0.13% 232
2024
Q2 		– Sell
-10,157
Closed -$7.9M – 941
2024
Q1 		$7.9M Buy
+10,157
New +$7.23M 0.76% 15
2018
Q4 		– Sell
-15,700
Closed -$1.69M – 701
2018
Q3 		$1.69M Buy
+15,700
New +$1.57M 0.28% 90

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bayesian Capital Management's LLY Position: Q2 2025 in Review

Bayesian Capital Management sold out of Eli Lilly (LLY) in Q2 2025, closing a stake of 473 shares — an estimated $391K sold.

Bayesian Capital Management first reported a position in LLY in Q3 2018 and held it in 4 quarters. The position peaked at $7.9M in Q1 2024. 3,906 funds tracked by Wall St. Rank hold LLY as of Q2 2025.

  • Bayesian Capital Management reported no remaining Eli Lilly position as of Q2 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 473 Eli Lilly shares in Q2 2025, an estimated $391K.
  • Bayesian Capital Management first reported a position in Eli Lilly in Q3 2018 and held it in 4 quarters.
  • Bayesian Capital Management's Eli Lilly position peaked at $7.9M in Q1 2024.
  • 3,906 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2025.

Based on Bayesian Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.